ANDA 206682

FRESENIUS

FDA Drug Application

Application #206682

Application Sponsors

ANDA 206682

FRESENIUS

Marketing Status

• Prescription: 001
• Prescription: 002

Application Products

001	INJECTABLE;INJECTION	EQ 1GM BASE/VIAL	0	NAFCILLIN SODIUM	NAFCILLIN SODIUM
002	INJECTABLE;INJECTION	EQ 2GM BASE/VIAL	0	NAFCILLIN SODIUM	NAFCILLIN SODIUM

FDA Submissions

UNKNOWN;

ORIG

1

AP

2019-12-10

STANDARD

Submissions Property Types

ORIG

1

Null

7

TE Codes

001	Prescription	AP
002	Prescription	AP

CDER Filings

FRESENIUS

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206682
            [companyName] => FRESENIUS
            [docInserts] => ["",""]
            [products] => [{"drugName":"NAFCILLIN SODIUM","activeIngredients":"NAFCILLIN SODIUM","strength":"EQ 1GM BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"NAFCILLIN SODIUM","activeIngredients":"NAFCILLIN SODIUM","strength":"EQ 2GM BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"12\/10\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2019-12-10
        )

)